Cirrhosis and Bacterial Infections

Romanian Journal of Gastroenterology

Volumn 12, Issue 4, 2003, Pages 297-302

  Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cirrhosis; Immune deficiency; Infection; Prognosis; Prophylaxis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN;

ACUTE PHASE RESPONSE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ASCITES; ASPIRATION; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG INDICATION; ESOPHAGUS VARICES BLEEDING; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INJURY; LIVER ABSCESS; LIVER CIRRHOSIS; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MALNUTRITION; MENINGITIS; META ANALYSIS; MICROFLORA; MORTALITY; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMONIA; PROGNOSIS; SIDE EFFECT; SKIN DEFECT; TUBERCULOSIS; UPPER GASTROINTESTINAL BLEEDING; URINARY TRACT INFECTION;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIAL INFECTIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER CIRRHOSIS; PERITONITIS; SURVIVAL RATE;

EID: 1642471995     PISSN: 12214167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Navasa M, Fernandez J, Rodcs J. Bacterial infections in liver cirrhosis. Ital J Gastroenterol Hepatol 1999; 31:616-625.
2. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33:41-48.
3. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140-148.
4. Sorensen HT, Thulstrup AM, Mellemkjar L, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol 2003; 56:88-93.
5. Thulstrup AM, Molle I, Svendsen N, Sorensen HT. Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study. Epidemiol Infect 2000; 124:221-225.
6. Molle I, Thulstrup AM, Vilstrup H, Sorensen HT. Increased risk and case fatality rate of pyogenic liver abscess in patients with liver cirrhosis: a nationwide study in Denmark. Gut 2001; 48:260-263.
7. Jepsen P, Vilstrup H, Mřller JK, Sřrensen HT. Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis. Hepatogastroenterology 2003; 50:2133-2136.
8. Thulstrup AM, Sorensen HT, Schonheyder HC, Moller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 2000; 31:1357-1361.
9. Xiol X, Castellvi JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23:719-723.
10. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5:463-467.
11. Bleichner G, Boulanger R, Squara P, Sollet JP, Parent A. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986; 73:724-726.
12. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108:1828-1834.
13. Hsieh WJ, Lin HC, Hwang SJ, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93:962-966.
14. Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20:34-38.
15. Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103:1267-1272.
16. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24:802-806.
17. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a metaanalysis. Hepatology 1999; 29:1655-1661.
18. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353(9147):139-142.
19. Calvet X, Nogueras C, Roque M, Sanfeliu I. Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis 2001; 33:414-419.
20. Scotiniotis IA, Lucey MR, Metz DC. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci 2001; 46:2744-2751.
21. Huber M, Rossle M, Siegerstetter V, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001; 48:541-544.
22. Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001; 127:443-450.
23. Soares-Weiser K, Brezis M, Tur-Kaspa R, Paul M, Yahav J, Leibovici L. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 2003; 38:193-200.